8FS-16632-19975
3 vaccinations
2 coded responses
20 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 195 / PA
- Registered
- 2021-05-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-12
Dose 1 — Pfizer-BioNTech
-
2021-05-03
Registered in v-safe
-
2021-05-03
Dose 2 — Pfizer-BioNTech
- 2021-05-03
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-05-05
- 2021-05-06
- 2021-05-07
- 2021-08-02
- 2021-11-01
-
2021-12-10
Dose 3 — Pfizer-BioNTech
-
2021-12-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-12
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fever · Headache, Joint painsAdult check-in
- 2021-12-13
- 2021-12-14
- 2021-12-19
-
2021-12-24
Survey response — day 14, dose 3MedDRA: Headache, Respiratory tract congestion — Feeling: Good · Be unable to do your normal daily activitiesFree text: Congestion, headacheMedDRA releases: 2024-11 · check-in free text available
- 2021-12-31
- 2022-01-07
- 2022-01-14
-
2022-01-21
Survey response — day 42, dose 3MedDRA: Cough, Respiratory tract congestion, Sneezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Congestion/sneezing/occasional coughMedDRA releases: 2024-11 · check-in free text available
- 2022-03-11
- 2022-06-10
- 2022-12-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-12 | Pfizer-BioNTech | |
| 2 | 2021-05-03 | Pfizer-BioNTech | |
| 3 | 2021-12-10 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 3
Symptoms: Congestion, headache
Release 11 — day 42, dose 3
Symptoms: Congestion/sneezing/occasional cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release